cough syrup

WHO issues alert against substandard India-made drugs linked to deaths in Uzbekistan

The WHO alert comes weeks after Uzbekistan said that 18 children died after consuming a syrup made by the company.

published on : 12th January 2023

Uzbekistan cough syrup case: Marion Biotech's production licence suspended; WHO issue alert

It said substandard medical products fail to meet quality standards or specifications and are therefore "out of specification."

published on : 12th January 2023

Cough syrup deaths in Uzbekistan: Noida firm stops syrup manufacturing 'for now', India begins probe 

Marion Biotech does not sell Dok-1 Max in India and its only export has been to Uzbekistan, an Uttar Pradesh government official said as inspection began at the company office in Noida.

published on : 29th December 2022

Cough syrup deaths: India seeks details from Uzbekistan on investigations 

MEA spokesperson Arindam Bagchi said consular assistance is being provided to some linked to the company who are facing legal action there.

published on : 29th December 2022

Uzbekistan cough syrup deaths: Marion Biotech into pharma, nutraceuticals, cosmetic products

Marion Biotech is a licensed manufacturer and holds the licence for manufacturing Dok-1 Max syrup and tablet for exports granted by the Drugs Controller, Uttar Pradesh.

published on : 29th December 2022

Cough syrup linked deaths in Uzbekistan: Samples collected, Drugs control organisation initiates probe

Hasan Harris, legal representative of Mario Biotech, said the governments of both countries is looking into the matter and inquiring.

published on : 29th December 2022

Uzbekistan says 18 children dead after consuming India-made cough syrup

Uzbekistan’s Ministry of Health said 18 of 21 children took Doc-1 Max syrup, manufactured by Indian company Marion Biotech Private Limited, as they were suffering from an acute respiratory disease. 

published on : 29th December 2022

Death of infants due to spurious cough syrup: SC dismisses J-K's plea against NHRC order on compensation

Ten children died in Ramnagar tehsil of Udhampur in December 2019 and January 2020 due to consumption of spurious cough syrup. 

published on : 11th November 2022

Cough syrup deaths in Gambia serious issue, says WHO chief scientist Soumya Swaminathan

Swaminathan was speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN).

published on : 21st October 2022

Indonesia bans sale of all syrup, liquid medication after death of 99 children

As many as 99 children died this year after taking syrup medicine containing ingredients linked to acute kidney injuries (AKI).

published on : 20th October 2022

Cough syrup tragedy evokes cry for tighter pharma checks

Looking at the facts of the case, the company should never be around today. Maiden Pharma was blacklisted by Bihar in 2011 for selling cough syrup that failed local standards tests.

published on : 16th October 2022

Merchants of death in Indian pharma lethal for nation

Unfortunately this is not the first such case, nor is likely to be the last. Vaccines made in haste indigenously during the pandemic had also exposed chinks in our armour.

published on : 16th October 2022

Cough syrups deaths: Govt panel says info shared by WHO so far inadequate to determine cause

Mentioning the observations, Dr Somani said, "The clinical features and the treatment received by the children as shared by WHO so far are inadequate to determine the aetiology.

published on : 15th October 2022

India in touch with Gambia over deaths linked to cough syrup

External Affairs Minister S Jaishankar held a telephonic conversation with his Gambian counterpart Mamadou Tangara on Thursday, and conveyed "deepest condolences on the deaths of young children".

published on : 14th October 2022

Panel to analyse WHO report on Gambia child deaths linked to Indian cough syrups; Haryana halts production

The committee will advise and recommend further action to India’s Drugs Controller General of India (DCGI) after the WHO submits all details.

published on : 13th October 2022

Manufacturing, testing violations detected during inspection of Maiden Pharmaceuticals: Officials

"Various documents were examined by the investigating team, which clearly indicates that the firm is not meeting the requirements of Drugs Rules, 1945 under Drugs and Cosmetics Act."

published on : 12th October 2022

Haryana govt halts all drug production at factory linked to Gambia deaths

"Taking cognisance of this, the state government has ordered that all drug production at this unit be stopped with immediate effect," Vij told PTI over phone.

published on : 12th October 2022

Orders issued to halt drug manufacturing at Maiden Pharma's Sonipat unit: Haryana minister Anil Vij

The report of the samples of four cough syrups which had been recently sent to the Central Drugs Laboratory in Kolkata for examination was awaited.

published on : 12th October 2022

Govt panel formed to study WHO report on deaths of 66 Gambian kids linked to 4 Indian syrups

The Central Drugs Standard Control Organisation took up the matter immediately with the Haryana State Regulatory Authority, under whose jurisdiction the drug manufacturing unit is located.

published on : 12th October 2022

Grief and outrage in Gambia over cough syrup deaths

Social media has been swamped by criticism of the healthcare system and by photos of the children who have died, most of whom were aged under five.

published on : 11th October 2022
1 2 >